Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Otx2 promotes granule cell precursor proliferation and Shh-dependent medulloblastoma maintenance in vivo.

El Nagar S, Chakroun A, Le Greneur C, Figarella-Branger D, Di Meglio T, Lamonerie T, Billon N.

Oncogenesis. 2018 Aug 13;7(8):60. doi: 10.1038/s41389-018-0070-6.

2.

A new genetically engineered mouse model of choroid plexus carcinoma.

El Nagar S, Zindy F, Moens C, Martin L, Plassard D, Roussel MF, Lamonerie T, Billon N.

Biochem Biophys Res Commun. 2018 Feb 5;496(2):568-574. doi: 10.1016/j.bbrc.2017.11.192. Epub 2018 Jan 12.

3.

Comprehensive interactome of Otx2 in the adult mouse neural retina.

Fant B, Samuel A, Audebert S, Couzon A, El Nagar S, Billon N, Lamonerie T.

Genesis. 2015 Nov;53(11):685-94. doi: 10.1002/dvg.22903. Epub 2015 Oct 23.

PMID:
26426291
4.
5.

Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?

Le Jeunne C, Billon N, Dandon A; participants of round table N° 3 of Giens XXVIII (th), Berdaï D, Adgibi Y, Bergmann JF, Bordet R, Carpentier A, Cohn E, Courcier S, Girault D, Goni S, Jolliet P, Liard F, Prot-Labarthe S, Simon T, Vernotte C, Westerloppe J.

Therapie. 2013 Jul-Aug;68(4):225-39. doi: 10.2515/therapie/2013041. Epub 2013 Aug 28. English, French.

6.

Prescriptions hors-AMM : comment en pratique les identifier, les encadrer, informer et les suivre ?

Le Jeunne C, Billon N, Dandon A; les participants à la table ronde N° 3 de Giens XXVIII :, Berdaï D, Adgibi Y, Bergmann JF, Bordet R, Carpentier A, Cohn E, Courcier S, Girault D, Goni S, Jolliet P, Liard F, Prot-Labarthe S, Simon T, Vernotte C, Westerloppe J.

Therapie. 2013 Jul-Aug;68(4):225-31. doi: 10.2515/therapie/2013039. French. No abstract available.

PMID:
27392725
7.

Loss of Otx2 in the adult retina disrupts retinal pigment epithelium function, causing photoreceptor degeneration.

Housset M, Samuel A, Ettaiche M, Bemelmans A, Béby F, Billon N, Lamonerie T.

J Neurosci. 2013 Jun 12;33(24):9890-904. doi: 10.1523/JNEUROSCI.1099-13.2013. Erratum in: J Neurosci. 2014 Apr 16;34(16):5732.

8.

PBX1: a novel stage-specific regulator of adipocyte development.

Monteiro MC, Sanyal M, Cleary ML, Sengenès C, Bouloumié A, Dani C, Billon N.

Stem Cells. 2011 Nov;29(11):1837-48. doi: 10.1002/stem.737. Erratum in: Stem Cells. 2012 Mar;30(3):585. Bouloumé, Anne [corrected to Bouloumié, Anne].

9.

Developmental origins of the adipocyte lineage: new insights from genetics and genomics studies.

Billon N, Dani C.

Stem Cell Rev. 2012 Mar;8(1):55-66. doi: 10.1007/s12015-011-9242-x. Review.

PMID:
21365256
10.

Comprehensive transcriptome analysis of mouse embryonic stem cell adipogenesis unravels new processes of adipocyte development.

Billon N, Kolde R, Reimand J, Monteiro MC, Kull M, Peterson H, Tretyakov K, Adler P, Wdziekonski B, Vilo J, Dani C.

Genome Biol. 2010;11(8):R80. doi: 10.1186/gb-2010-11-8-r80. Epub 2010 Aug 3.

11.

The FunGenES database: a genomics resource for mouse embryonic stem cell differentiation.

Schulz H, Kolde R, Adler P, Aksoy I, Anastassiadis K, Bader M, Billon N, Boeuf H, Bourillot PY, Buchholz F, Dani C, Doss MX, Forrester L, Gitton M, Henrique D, Hescheler J, Himmelbauer H, Hübner N, Karantzali E, Kretsovali A, Lubitz S, Pradier L, Rai M, Reimand J, Rolletschek A, Sachinidis A, Savatier P, Stewart F, Storm MP, Trouillas M, Vilo J, Welham MJ, Winkler J, Wobus AM, Hatzopoulos AK; Functional Genomics in Embryonic Stem Cells Consortium.

PLoS One. 2009 Sep 3;4(9):e6804. doi: 10.1371/journal.pone.0006804.

12.

Information sheets and informed consent forms for clinical study participants: towards standardised recommendations?

Chassany O, Bernard-Harlaut M, Guy G, Billon N.

Therapie. 2009 May-Jun;64(3):161-86. doi: 10.2515/therapie/2009035. Epub 2009 Aug 13. Review. English, French.

13.

Developmental origin of adipocytes: new insights into a pending question.

Billon N, Monteiro MC, Dani C.

Biol Cell. 2008 Oct;100(10):563-75. doi: 10.1042/BC20080011. Review.

PMID:
18793119
14.

Commitment of mouse embryonic stem cells to the adipocyte lineage requires retinoic acid receptor beta and active GSK3.

Monteiro MC, Wdziekonski B, Villageois P, Vernochet C, Iehle C, Billon N, Dani C.

Stem Cells Dev. 2009 Apr;18(3):457-63. doi: 10.1089/scd.2008.0154.

PMID:
18690793
15.

[State of unmet medical needs in France in 2006: necessity of reinforcing research effort].

Jouan-Flahault C, Billon N, Castaigne A, Henry YD, Omnes C, Puech A, Rosilio M, Lassale C.

Therapie. 2007 Sep-Oct;62(5):393-415. doi: 10.2515/therapie:2007069. Epub 2008 Jan 19. French.

PMID:
18206102
16.

The generation of adipocytes by the neural crest.

Billon N, Iannarelli P, Monteiro MC, Glavieux-Pardanaud C, Richardson WD, Kessaris N, Dani C, Dupin E.

Development. 2007 Jun;134(12):2283-92. Epub 2007 May 16.

17.

Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells.

Zaragosi LE, Billon N, Ailhaud G, Dani C.

Stem Cells. 2007 Mar;25(3):790-7. Epub 2006 Dec 7.

18.
19.

A dynamic switch in the replication timing of key regulator genes in embryonic stem cells upon neural induction.

Perry P, Sauer S, Billon N, Richardson WD, Spivakov M, Warnes G, Livesey FJ, Merkenschlager M, Fisher AG, Azuara V.

Cell Cycle. 2004 Dec;3(12):1645-50. Epub 2004 Dec 4.

PMID:
15611653
20.

Roles for p53 and p73 during oligodendrocyte development.

Billon N, Terrinoni A, Jolicoeur C, McCarthy A, Richardson WD, Melino G, Raff M.

Development. 2004 Mar;131(6):1211-20. Epub 2004 Feb 11.

21.

Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1).

Billon N, Jolicoeur C, Tokumoto Y, Vennström B, Raff M.

EMBO J. 2002 Dec 2;21(23):6452-60.

22.

Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells.

Billon N, Jolicoeur C, Ying QL, Smith A, Raff M.

J Cell Sci. 2002 Sep 15;115(Pt 18):3657-65.

23.

Role of thyroid hormone receptors in timing oligodendrocyte differentiation.

Billon N, Tokumoto Y, Forrest D, Raff M.

Dev Biol. 2001 Jul 1;235(1):110-20.

24.

Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation.

Billon N, Carlisi D, Datto MB, van Grunsven LA, Watt A, Wang XF, Rudkin BB.

Oncogene. 1999 May 6;18(18):2872-82.

25.
26.
27.

Comparison of tolerance to intravenous nitroglycerin during nicorandil and intermittent nitroglycerin patch in healthy volunteers.

Tabone X, Funck-Brentano C, Billon N, Jaillon P.

Clin Pharmacol Ther. 1994 Dec;56(6 Pt 1):672-9.

PMID:
7995010
28.

Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteers.

Dimier-David L, Billon N, Costagliola D, Jaillon P, Funck-Brentano C.

Br J Clin Pharmacol. 1994 Aug;38(2):109-15.

29.

Clinical evaluation of pain during subcutaneous injections of low molecular weight heparins in healthy volunteers.

Billon N, Gloaguen F, Funck-Brentano C, Jaillon P.

Br J Clin Pharmacol. 1994 Apr;37(4):395-7.

Supplemental Content

Loading ...
Support Center